AC Immune Inc (ACIU) - Narx-foyda koeffitsiyenti

AC Immune Corp - ACIU emitenti grafik logotipi

AC Immune (ACIU) sutka davomida molekulyar tahlilni amalga oshiruvchi avtomatlashtirilgan stansiyalardan foydalangan holda Altsgeymer kasalligi davolash vositalarini qidirishni tezlashtirmoqda. O'sish strategiyasi innovatsion testlar va vaksinalarni tijoratlashtirish uchun korporativ texnologik gigantlar bilan hamkorlik qilishga tayanadi. Joriyl PE koeffitsiyenti -4.10 ni tashkil etadi. Ushbu grafikda ko'rsatilgan AC Immune kompaniyasining narxlar dinamikasi neyrodegenerativ patologiyalar uchun terapiya vositalarini ishlab chiqishda ekologik standartlar va bioetikaga qat'iy rioya qilinishi bilan to'ldirilgan.

AC Immune SA (ACIU) - P/E multiplikatori 04.07.2022dan 10.11.2026gacha

AC Immune kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi acimmune.com|ACIU - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor bahosi AC Immune SA|ACIU - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans bo'yicha xususiy kapital ma'lumotlari:
Aksiyaning buxgalteriya qiymati AC Immune|ACIU - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi acimmune.com|ACIU - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati AC Immune|ACIU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati AC Immune Inc|ACIU - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AC Immune SA|ACIU - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi AC Immune|Shoshilinch likvidlik acimmune.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
ACIU - Sof foyda|Prognoz qilingan kelajakdagi foyda AC Immune|ACIU - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati AC Immune S.A.|ACIU - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati AC Immune SA|ACIU - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) AC Immune|ACIU - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi acimmune.com|ACIU - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi AC Immune
Kompaniyaning umumiy tahlili:ACIU, acimmune.com
AC Immune brend mahsuloti

P/E koeffitsiyenti foydaning bir birligining bozor qiymatini aks ettiradi va aksiya narxining sof foydaga nisbatini hisoblagan holda investitsiyalarning qoplanish muddatini belgilaydi. -4.10 qiymati choraklik hisobotlarga juda sezgir hisoblanadi, chunki foydadagi har qanday tebranishlar baholashni keskin o'zgartiradi. P/E baholash dinamikasini tahlil qilish orqali investor vaqtincha pasayishni tizimli inqirozdan ajratib olishi mumkin. AC Immune (ACIU) uchun ushbu ko'rsatkich juda muhimdir, chunki Altsgeymerga qarshi dori ishlab chiqishni avtomatlashtirish sintezni tezlashtiradi, biroq uzoq davom etadigan klinik sinovlar monetizatsiyada vaqt kechikishini yuzaga keltiradi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori biogen.com|P/E multiplikatori NBIX|Narx-foyda koeffitsiyenti Regencell Bioscience Ltd RGC|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACAD|Xenon Pharmaceuticals - P/E multiplikatori|Biznesning o‘zini qoplash muddati vikingtherapeutics.com VKTX|Supernus (SUPN) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Catalyst Pharma|Narxning foydaga nisbati Denali Therapeutics Inc|Narx-foyda koeffitsiyenti Harmony Corp (HRMY)|Narx-foyda koeffitsiyenti BHVN (Biohaven Ltd.)|P/E multiplikatori amylyx.com (AMLX)|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|Anavex Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CeriBell EEG|PRTA: P/E multiplikatori|Alector (ALEC) - P/E multiplikatori|ANNX (Annexon) - P/E multiplikatori|Narx-foyda koeffitsiyenti Omeros Corp. (OMER)|P/E multiplikatori NGNE|Biznesning o‘zini qoplash muddati Voyager Corp|Neumora Therapeutics - Narx-foyda koeffitsiyenti|P/E multiplikatori scilexholding.com SCLX|TVGN - Narxning foydaga nisbati|ACOG (Alpha Cognition) - Narx-foyda multiplikatori|CGTX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Inhibikase Pharma (IKT)|Narx-foyda koeffitsiyenti SAVA|P/E multiplikatori Assertio Therapeutics|Narxning foydaga nisbati Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Ovid Therapeutics OVID|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalizatsiyaning foydaga nisbati|CervoMed Inc. - P/E multiplikatori|ATHE - P/E multiplikatori|CLNN: P/E multiplikatori|Narx-foyda koeffitsiyenti PepGen|Narx-foyda koeffitsiyenti JUNS|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Biznesning o‘zini qoplash muddati gracetx.com|Narxning foydaga nisbati Firefly Neuroscience AIFF|KLTO - Narx-foyda koeffitsiyenti|NRSN - Narxning foydaga nisbati|Reviva Pharmaceuticals, Inc. (RVPH) - Narx-foyda koeffitsiyenti|MTVA (metaviatx.com) - Narx-foyda koeffitsiyenti|neuraxis.com (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical Technologies, Inc.|Narx-foyda multiplikatori PASG (Passage Bio Corp)|P/E multiplikatori NEUP|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (Athira Pharma, Inc.)|P/E multiplikatori addextherapeutics.com ADXN|Alzamend - P/E multiplikatori|Cyclerion Therapeutics (CYCN) - Narx-foyda koeffitsiyenti|PTIX: P/E multiplikatori|KTTA - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti CRGT|P/E multiplikatori avenuetx.com|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|Cara Therapeutics Inc. - Narx-foyda multiplikatori|P/E multiplikatori CHRO (Chromocell Therapeutics Corporation)|Eliem Therapeutics, Inc. (ELYM) - Kapitalizatsiyaning foydaga nisbati|ITCI: Narx-foyda koeffitsiyenti|LBPH - P/E multiplikatori|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGen Biotech Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NeuroBo|Kapitalizatsiyaning foydaga nisbati Sage Therapeutics Inc SAGE|P/E multiplikatori SNPX|P/E multiplikatori trevena.com (TRVN)|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|WENA - Narx-foyda koeffitsiyenti|CERE: Narx-foyda koeffitsiyenti